icon-folder.gif   Conference Reports for NATAP  
 
  15th European AIDS Conference (EACS)
October 21-24, 2015
Barcelona
Back grey_arrow_rt.gif
 
 
 
Changes in cognitive function over 96 weeks after initiating darunavir/ritonavir with either raltegravir or tenofovir-emtricitabine; NEAT 001 / ANRS 143 randomised controlled study
 
 
  Reported by Jules Levin
EACS 2015 Oct 21-24 Barcelona, Spain -15th European AIDS Conference
 
Alan Winston, Wolfgang Stöhr, Andrea Antinori, Helene Amieva, Philippe Perré, Stephane De Wit, Jacques Reynes, Mark Gompels, Antonella d'Arminio Monforte, Jose-Maria Gatell, Anton Pozniak, Abdel Babiker, François Raffi and Laura Richert for the NEAT 001/ANRS 143 Study Group

EACS1.gif

EACS2.gif

EACS3.gif

EACS4.gif

EACS5.gif

EACS6.gif

EACS7.gif

EACS8.gif

EACS9.gif

EACS10.gif

EACS11.gif

EACS12.gif

EACS13.gif

EACS14.gif

EACS15.gif